Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Biosimilar Insulin

Share Post:

What is biosimilar insulin?

Biosimilar insulin refers to the biological copy of an approved insulin product. One of the best examples is Semglee, which is a copy of Lantus. In terms of its cost, biosimilar products are cheaper compared to their original counterparts.

In understanding biosimilars, it is necessary to learn about biologics first. A biologic drug refers to a medication made from living organisms. It can be classified by its large and complex molecules, which are considered more potent. Some biologics can be in the form of vaccines, cell therapies, and other medications. Ozempic and Lantus are two popular examples.

Now, how can biosimilars become applicable today?

If the patent of a certain biologic drug expires, its biosimilar version can be approved by the FDA and gets introduced into the market. This is how biosimilar insulin becomes available in pharmacies and various drugstores worldwide.

Reports suggest that only a few new insulin products have infiltrated the market. It means that there may be many insulin products that have been rejected for retail. However, as the patent for some insulin products expire, there will be more options for people with diabetes to manage their condition better. Additionally, the affordability of biosimilar insulins can make it more accessible to common people.

Is biosimilar insulin different from a generic version?

Yes. A biosimilar insulin is different from a generic version of a branded insulin medication. How? A generic medicine is the exact copy of an FDA-approved drug. If a drug’s patent expires, other pharmaceuticals or manufacturers can produce an unbranded replica of the same drug. This is how they are called generics. If differentiated between biologics, generics use small-molecule drugs compared to biologics’ large and complex components.

In terms of cost, biosimilar insulin and generics are cheaper. That is why people who have concerns about their insulin cost are advised to ask for alternatives. These alternatives can only come in between biosimilar and authorized generic insulins.

List of Biosimilar Insulin

The following is the list of biosimilar insulins approved by the Food and Drug Administration:

Biosimilar NameReference Insulin/Product
RezvoglarLantus (insulin glargine)
SemgleeLantus (Insulin glargine)
BasaglarLantus (Insulin glargine)
AdmelogHumalog (insulin lispro)
TruapiNovoRapid (insulin aspart)
Profile image of CDI Staff Writer

Written by CDI Staff WriterOur internal team are experts in many subjects. on January 23, 2023

Related Articles

Diabetes, Insulin
Common and Rare Lantus Side Effects: What to Expect

Summary: Lantus, a long-acting insulin, helps manage blood sugar levels in people with diabetes. While generally safe, it may cause common side effects such as low blood sugar and injection…

Read More
Diabetes, Insulin
How the Lantus Savings Card Can Help You Cut Insulin Costs

Summary: The Lantus Savings Card helps individuals with commercial insurance significantly reduce the cost of Lantus, potentially lowering out-of-pocket expenses to as little as $0 per month. This article explains…

Read More
Diabetes, Insulin
Lantus Insulin Price Breakdown: Affordable Options and Savings Tips

Summary: The cost of Lantus insulin can be a significant burden for many diabetes patients. However, exploring Lantus savings options, such as the Lantus savings card, can help make this…

Read More
Diabetes, Insulin
Humalog Insulin Pump: How It Works and Why It’s Effective

Summary: The Humalog insulin pump offers a convenient and precise way for diabetes patients to manage blood sugar levels. It delivers insulin continuously, mimicking natural insulin release, and provides better…

Read More